Which listed companies produce drugs against avian influenza?

The listed companies engaged in the poultry and livestock vaccine industry in my country mainly include China Animal Husbandry Co., Ltd., Jinyu Group, and Zhenghong Technology

China Animal Husbandry Co., Ltd. (600195): approved by the Ministry of Agriculture to produce avian influenza vaccines The first business. The market sales volume of livestock and poultry vaccines produced accounts for more than 30% of the country's market share. The domestic market share of livestock vaccines and special vaccines is more than 40%, ranking first in the country. Its annual sales volume reaches more than 10 billion birds (parts). The highly pathogenic avian influenza inactivated vaccine produced by the company will play a great role in my country's battle against avian influenza.

Jinyu Group (600201): a livestock special vaccine manufacturer designated by the Ministry of Agriculture. The wholly-owned subsidiary Inner Mongolia Biopharmaceutical Factory's GMP standard project with an annual output of 10 billion chicks has been put into production. The project has added 17 vaccines and successfully passed the GMP certification of the Ministry of Agriculture, becoming the first stronghold in the country to obtain GMP certification. Inactivated virus vaccine workshop, the comprehensive research and production capacity of avian influenza vaccine are at the leading level in the country. The avian influenza epidemic will make its newly put into production vaccine production line a new profit growth point.

Zhenghong Technology (000702): Its subsidiary Fuwei Biotechnology is the first domestic high-tech biotechnology enterprise to pass the ministerial-level scientific and technological achievements appraisal in the field of natural plant extracts. The "Lvwei" series of biological genetic drugs developed by it to prevent and treat avian influenza are widely used in the prevention and treatment of avian influenza viruses that have ravaged Southeast Asia and even the world in recent years.

In addition: Currently, five companies engaged in the production of poultry and livestock vaccines in the two cities include China Animal Husbandry Co., Ltd., Jinyu Group, Donghu High-tech, Huashen Group, and Shenghua Baker. Others involved in the poultry and livestock vaccine industry include Yahua Seed Industry, Qinfeng Agriculture, Changchun High-tech, Guangdong Hongyuan, Harbin Pharmaceutical Group, Zhenghong Technology, etc., but the leading production companies are China Animal Husbandry Co., Ltd. (600195) and Jinyu Group (600201). Among them, China Animal Husbandry Co., Ltd. is the first company approved by the Ministry of Agriculture to produce avian influenza vaccines. The market sales volume of livestock and poultry vaccines it produces accounts for more than 30% of the country’s market share. The domestic market share of livestock vaccines and special vaccines is even more More than 40, ranking first in the country; Jinyu Group has also obtained special approval from the Ministry of Agriculture to produce the highly pathogenic avian influenza H5N1 inactivated vaccine. The company's annual output of 10 billion poultry vaccines GMP standard project has been put into production, and the project products There are 17 new vaccines, which are expected to make a greater contribution to the company amid strong market demand.

At present, there are five companies engaged in the production of poultry and livestock vaccines in the two cities, including China Animal Husbandry Co., Ltd., Jinyu Group, Donghu High-tech, Huashen Group, and Shenghua Baker. Others involved in the poultry and livestock vaccine industry include Yahua Seed Industry, Qinfeng Agriculture, Changchun High-tech, Yue Hongyuan, Harbin Pharmaceutical Group, Zhenghong Technology, etc., but the leading production companies are China Animal Husbandry Co., Ltd. (600195) and Jinyu Group (600201). Among them, China Animal Husbandry Co., Ltd. is the first company approved by the Ministry of Agriculture to produce avian influenza vaccines. The market sales volume of livestock and poultry vaccines it produces accounts for more than 30% of the country's market share. The domestic market share of livestock vaccines and special vaccines is even more. More than 40, ranking first in the country; Jinyu Group has also obtained special approval from the Ministry of Agriculture to produce the highly pathogenic avian influenza H5N1 inactivated vaccine. The company's annual output of 10 billion poultry vaccines GMP standard project has been put into production, and the project products There are 17 new vaccines, which are expected to make a greater contribution to the company amid strong market demand.